C07C 235/34
Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms
Official title: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07C235/34 (Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms) appears on 655 US grants and 534 published applications in this corpus.
Search patents in C07C- Granted patents
- 655
- Published applications
- 534
- Assignees
- 366
- Inventors
- 1,814
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 12 | 0 |
| 1992 | 14 | 0 |
| 1993 | 28 | 0 |
| 1994 | 18 | 0 |
| 1995 | 19 | 0 |
| 1996 | 26 | 0 |
| 1997 | 49 | 0 |
| 1998 | 19 | 0 |
| 1999 | 24 | 0 |
| 2000 | 25 | 0 |
| 2001 | 24 | 7 |
| 2002 | 22 | 19 |
| 2003 | 20 | 20 |
| 2004 | 16 | 41 |
| 2005 | 11 | 31 |
| 2006 | 19 | 21 |
| 2007 | 20 | 27 |
| 2008 | 14 | 36 |
| 2009 | 24 | 42 |
| 2010 | 21 | 21 |
| 2011 | 18 | 20 |
| 2012 | 22 | 25 |
| 2013 | 19 | 27 |
| 2014 | 21 | 26 |
| 2015 | 20 | 16 |
| 2016 | 23 | 26 |
| 2017 | 12 | 6 |
| 2018 | 6 | 20 |
| 2019 | 12 | 20 |
| 2020 | 14 | 16 |
| 2021 | 13 | 14 |
| 2022 | 9 | 9 |
| 2023 | 10 | 10 |
| 2024 | 11 | 15 |
| 2025 | 6 | 12 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- Stable heavy isotopes in amide functional groups and uses thereof7 Apr 2026US 12,595,260 B2Risen (Suzhou) Pharma Tech Co., Ltd.
- Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway7 Apr 2026US 12,595,278 B2Reata Pharmaceuticals, Inc.
- Cinnamic amide derivative having FXR activating effect, pharmaceutical composition containing the same as active ingredient, and method for preparing the same17 Feb 2026US 12,552,755 B2Kyungsung University Industry Cooperation Foundation
- L-DOPA and/or DOPA decarboxylse inhibitors conjugated to sugar for the treatment of dopamine-responsive disorders27 Jan 2026US 12,533,417 B2B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Trpv1 agonist and uses thereof17 Sep 2026US 2026/0274802 A1SciTherm Therapeutics Corporation
- Pharmaceutical salt of polyamine derivative, crystal form thereof, and preparation method therefor9 Jul 2026US 2026/0193171 A1Wuhan Wuyao Sci&Tech Co., Ltd
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising phenethyl cinnamamide derivative compound as active ingredient25 Jun 2026US 2026/0174712 A1Knu-Industry Cooperation Foundation
Most cited
By later US patents
- Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents217US 5,688,819 AAllergan, Inc. · 1997
- Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents177US 6,403,649 B1Allergan Sales, Inc. · 2002
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Immunotherapeutic agents153US 5,929,117 ACelgene Corporation · 1999